BridgeMD
Tests treatment safety and results for Tooth Loss
Official title PMCF Study on the Effectiveness and Safety of BIODENTOSS® and DWC® Dental Implants and Superstructures
ClinicalTrials.gov ID: NCT07633665
What this study is testing
- What it's testing
- This prospective, single-center, interventional post-market clinical follow-up (PMCF) study aims to evaluate the early-term (24 months post-implantation) safety and efficacy of CE-marked BIODENTOSS® and DWC ® Dental Implants and Superstructures in patients requiring dental restoration for tooth loss.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older,
- Male or female,
- people with missing tooth who require dental implant treatment,
- At least 2 months elapsed since tooth extraction,
- General health status suitable for implantation,
You likely can't join if
- Suspected or confirmed pregnancy or breastfeeding,
- Disorders preventing adequate daily oral hygiene,
- Hypersensitivity/allergy to titanium or implant components,
- Inappropriate interarch relationship or parafunction (e.g., bruxism),
- Bone/soft tissue deficiency requiring augmentation,
- Active periodontal infection or untreated oral pathologies,
See the full eligibility criteria
- 18 years of age or older,
- Male or female,
- people with missing tooth who require dental implant treatment,
- At least 2 months elapsed since tooth extraction,
- General health status suitable for implantation,
- Not legally restricted (e.g., soldier, convict),
- Provision of signed Informed Consent Form (ICF)
- Suspected or confirmed pregnancy or breastfeeding,
- Disorders preventing adequate daily oral hygiene,
- Hypersensitivity/allergy to titanium or implant components,
- Inappropriate interarch relationship or parafunction (e.g., bruxism),
- Bone/soft tissue deficiency requiring augmentation,
- Active periodontal infection or untreated oral pathologies,
- Unstable systemic diseases affecting wound healing (e.g., diabetes),
- Use of immunosuppressive drug therapy due to systemic disorders, organ transplantation, or any other medical conditions,
- Hematological disorders or current use of anticoagulants (such as Warfarin, dabigatran or related therapies),
- Presence of osteoporosis and/or any disease condition affecting bone metabolism,
- Presence of an active systemic infection, or any health condition or ongoing treatment (e.g., radiotherapy, bisphosphonate therapy) that contraindicates elective surgery,
- Recent myocardial infarction or cerebrovascular event,
- Individuals who consume high doses of alcohol, cigarettes, or tobacco products and are unable to control their usage,
- Participation in another treatment clinical study.
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.